155
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Human Formyl Peptide Receptor 1 (FPR1) c.32C>T SNP is Associated with Decreased Soluble E-selectin Levels

, , , , , , , , , & show all
Pages 951-959 | Published online: 17 Jun 2009

Bibliography

  • Prossnitz ER , YeRD: The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function.Pharmacol. Ther.74 , 73–102 (1997).
  • Le Y , HuJ, GongW et al.: Expression of functional formyl peptide receptors by human astrocytoma cell lines.J. Neuroimmunol.111 , 102–108 (2000).
  • Schiffmann E , ShowellHV, CorcoranBA, WardPA, SmithE, BeckerEL: The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli.J. Immunol.114 , 1831–1837 (1975).
  • Le Y , MurphyPM, WangJM: Formyl-peptide receptors revisited.Trends Immunol.23 , 541–548 (2002).
  • Murphy PM : The molecular biology of leukocyte chemoattractant receptors.Annu. Rev. Immunol.12 , 593–633 (1994).
  • Le Y , YangY, CuiY et al.: Receptors for chemotactic formyl peptides as pharmacological targets.Int. Immunopharmacol.2 , 1–13 (2002).
  • Bao L , GerardNP, EddyRL Jr, Shows TB, Gerard C: Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics13 , 437–440 (1992).
  • Murphy PM , OzçelikT, KenneyRT, TiffanyHL, McDermottD, FranckeU: A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family.J. Biol. Chem.267 , 7637–7643 (1992).
  • Ye RD , CavanaghSL, QuehenbergerO, ProssnitzER, CochraneCG: Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor.Biochem. Biophys. Res. Commun.184 , 582–589 (1992).
  • Nomura H , NielsenBW, MatsushimaK: Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors.Int. Immunol.5 , 1239–1249 (1993).
  • Migeotte I , CommuniD, ParmentierM: Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses.Cytokine Growth Factor Rev.17 , 501–519 (2006).
  • Perez HD , HolmesR, KellyE, McClaryJ, AndrewsWH: Cloning of a cDNA encoding a receptor related to the formyl peptide receptor of human neutrophils.Gene118 , 303–304 (1992).
  • Gao JL , ChenH, FilieJD, KozakCA, MurphyPM: Differential expansion of the N-formyl peptide receptor gene cluster in human and mouse.Genomics51 , 270–276 (1998).
  • Haviland DL , BorelAC, FleischerDT, HavilandJC, WetselRA: Structure, 5´-flanking sequence, and chromosome location of the human N-formyl peptide receptor gene. A single-copy gene comprised of two exons on chromosome 19q.13.3 that yields two distinct transcripts by alternative polyadenylation.Biochemistry32 , 4168–4174 (1993).
  • Gunji T , OnouchiY, NagasawaT et al.: Functional polymorphisms of the FPR1 gene and aggressive periodontitis in Japanese.Biochem. Biophys. Res. Commun.364 , 7–13 (2007).
  • Seifert R , Wenzel-SeifertK: Defective Gi protein coupling in two formyl peptide receptor mutants associated with localized juvenile periodontitis.J. Biol. Chem.276 , 42043–42049 (2001).
  • Jones BE , MiettinenHM, JesaitisAJ, MillsJS: Mutations of F110 and C126 of the formyl peptide receptor interfere with G-protein coupling and chemotaxis.J. Periodontol.74 , 475–484 (2003).
  • Zhang Y , SyedR, UygarC et al.: Evaluation of human leukocyte N-formyl peptide receptor (FPR1) SNPs in aggressive periodontitis patients.Genes Immun.4 , 22–29 (2003).
  • Sahagun-Ruiz A , CollaJS, JuhnJ, Gao J-L, Murphy PM, McDermott DH: Contrasting evolution of the human leukocyte N-formyl peptide receptor subtypes FPR and FPRL1R. Genes Immun.2 , 335–342 (2001).
  • Gwinn MR , SharmaA, De Nardin E: Single nucleotide polymorphisms of the N-formyl peptide receptor in localized juvenile periodontitis. J. Periodontol.70 , 1194–1201 (1999).
  • Bhattacharya M , WangJ, RibeiroFM et al.: Analysis of a missense variant of the human N-formyl peptide receptor that is associated with agonist-independent β-arrestin association and indices of inflammation.Pharmacogenomics7 , 190–199 (2007).
  • Siest G , VisvikisS, HerbethB et al.: Objectives, design and recruitment of a familial and longitudinal cohort for studying gene–environment interactions in the field of cardiovascular risk: the STANISLAS cohort.Clin. Chem. Lab. Med.36 , 35–42 (1998).
  • Ponthieux A , HerbethB, DroeschS, HaddyN, LambertD, VisvikisS: Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study.Atherosclerosis172 , 299–308 (2004).
  • Berrahmoune H , HerbethB, LamontJV et al.: Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort.Clin. Chem. Lab. Med.45 , 1339–1346 (2007).
  • Miller SA , DekesDD, PoleskyHF: A simple salting-out procedure for extracting DNA from human nucleated cells.Nucleic Acids Res.16 , 1215 (1988).
  • Blann AD , DavisA, MillerJP, McCollumCN: Von Willebrand factor and soluble E-selectin in hyperlipidaemia: relationship to lipids and vascular disease.Am. J. Hematol.55 , 15–23 (1997).
  • Kowalska I , StraczkowskiM, SzelachowskaM et al.: Circulating E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in men with coronary artery disease assessed by angiography and disturbances of carbohydrate metabolism.Metabolism51 , 733–736 (2002).
  • Sass C , PallaudC, ZannadF, VisvikisS: Relationship between E-selectin L/F554 polymorphism and blood pressure in the Stanislas cohort.Hum. Genet.107 , 58–61 (2000).
  • Gao JL , LeeEJ, MurphyPM: Impaired antibacterial host defense in mice lacking the N-formyl peptide receptor.J. Exp. Med.189 , 657–662 (1999).
  • Ruchaud-Sparagano MH , WalkerTR, RossiAG, HaslettC, DransfieldI: Soluble E-selectin acts in synergy with platelet-activating factor to activate neutrophil β 2-integrins. Role of tyrosine kinases and Ca2+ mobilization.J. Biol. Chem.275 , 15758–15764 (2000).
  • Bevilacqua MP , NelsonRM: Selectins.J. Clin. Invest.91 , 379–387 (1993).
  • Carlos TM , HarlanJM: Leukocyte-endothelial adhesion molecules.Blood84 , 2068–2101 (1994).
  • McMeekin SR , DransfieldI, RossiAG, HaslettC, WalkerTR: E-selectin permits communication between PAF receptors and TRPC channels in human neutrophils.Blood107 , 4938–4945 (2006).
  • Ley K , AlliettaM, BullardDC, MorganS: Importance of E-selectin for firm leukocyte adhesion in vivo.Circ. Res.83 , 287–294 (1998).
  • Rossi B , ConstantinG: Anti-selectin therapy for the treatment of inflammatory diseases.Inflamm. Allergy Drug Targets7 , 85–93 (2008).
  • Fujita T , FujimotoM, MatsushitaT et al.: Phase-dependent roles of E-selectin during chronic contact hypersensitivity responses.Am. J. Pathol.170 , 1649–1658 (2007).
  • Labow MA , NortonCR, RumbergerJM et al.: Characterization of E-selectin-deficient mice: demonstration of overlapping function of the endothelial selectins.Immunity1 , 709–720 (1994).
  • Ford ES , GaluskaDA, GillespieC, WillJC, GilesWH, DietzWH: C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988–1994.J. Pediatr.138 , 486–92 (2001).
  • Roberts WL , SedrickR, MoultonL, SpencerA, RifaiN: Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications.Clin. Chem.46 , 461–468 (2000).
  • Roberts WL , MoultonL, LawTC et al.: Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2.Clin. Chem.47 , 418–425 (2001).
  • Ledue TB , RifaiN: Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment.Clin. Chem.49 , 1258–1271 (2003).
  • Yeboah J , KleinK, BrosnihanB, ReboussinD, HerringtonDM: Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.Menopause15 , 1060–1064 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.